Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed Nov 5, 2026

Form type

SCHEDULE 13G/A

Filing date

Nov 5, 2026

Accession number

0000315066-26-002679

Filer

Avalo Therapeutics, Inc. (CIK 1534120)